VBAC
VBAC vaginal birth after cesarean candidacy criteria management
Management of HIV in Pregnancy and the Postpartum Period
Page 121
VBAC uterine rupture risk factors outcomes trial of labor
Medication Abortion Between 14 0/7 and 27 6/7 Weeks of Gestation
Page 6
| Factor | Detail |
|---|---|
| Prior cesarean incision | Low transverse uterine incision |
| Number of prior cesareans | 1 (possibly 2 — see below) |
| Indication for prior cesarean | Non-recurring (e.g., breech, fetal distress) |
| Prior vaginal delivery | Especially prior VBAC — most favorable predictor |
| Adequate pelvis | Clinical assessment |
| Gestational age | < 40 weeks (lower success after 41 weeks) |
| Spontaneous labor onset | Higher success than induction |
| Absolute | Relative |
|---|---|
| Prior classic (vertical) uterine incision | ≥ 2 prior cesareans (no prior vaginal delivery) |
| Prior T-shaped or J-shaped incision | Short inter-delivery interval (< 18 months) |
| Prior uterine rupture | Macrosomia (> 4,000–4,500 g) |
| Prior transmyometrial surgery (e.g., myomectomy through cavity) | Unknown uterine scar type |
| Placenta previa / other delivery contraindication | Labor induction (especially prostaglandins) |
| Parameter | Value |
|---|---|
| Risk with TOLAC (low transverse scar) | 0.5–0.9% (~1 in 150–200) |
| Risk with elective repeat cesarean (ERCS) | ~0.02% (scar dehiscence, not true rupture) |
| Risk with prior classic incision | 4–9% |
| Risk with prior uterine rupture | 6–32% |
| Outcome | Successful VBAC | Failed TOLAC | ERCS |
|---|---|---|---|
| Maternal mortality | Lowest | Higher | Intermediate |
| Uterine rupture | 0.5–0.9% | Included above | ~0.02% |
| Transfusion | Low | Higher | Intermediate |
| Hysterectomy | Low | Higher | Low |
| Neonatal respiratory morbidity | Low (benefit) | — | Higher (transient tachypnea) |
| NICU admission | Low | Higher | Intermediate |
| Perinatal death (attributable) | Very low | ~0.1% | Very low |
| Future pregnancy placenta accreta spectrum | Lowest | — | Increases with each cesarean |